Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens

Autor: Cyril C. Y. Yip, Kwok-Hung Chan, Tom Wai-Hin Chung, Stephen Kwok-Wing Tsui, Ivan Hung, Jasper Fuk-Woo Chan, Chi-Chun Ho, Anthony Raymond Tam, Helen Shuk-Ying Chan, Zijiao Zou, Kwok-Yung Yuen, Anthony Chin-Ki Ng, Kit-Hang Leung, Kelvin K. W. To, Agnes Yim Fong Fung, Sally C. Y. Wong, Owen Tak-Yin Tsang, Vincent C.C. Cheng
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
genome subtraction
viruses
clinical evaluation
specificity
medicine.disease_cause
Genome
lcsh:Chemistry
COVID-19 Testing
nsp2
COVID-19-nsp2 assay
lcsh:QH301-705.5
Spectroscopy
Coronavirus
Reverse Transcriptase Polymerase Chain Reaction
Subtraction
virus diseases
General Medicine
Computer Science Applications
GolayMetaMiner
Real-time polymerase chain reaction
COVID-19
sensitivity
real-time RT-PCR
SARS-CoV-2
RNA
Viral

Coronavirus Infections
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Concordance
Pneumonia
Viral

030106 microbiology
Genome
Viral

Biology
Real-Time Polymerase Chain Reaction
Sensitivity and Specificity
Article
Catalysis
Inorganic Chemistry
Betacoronavirus
03 medical and health sciences
medicine
Humans
Physical and Theoretical Chemistry
Pandemics
Molecular Biology
Cycle threshold
Clinical Laboratory Techniques
Organic Chemistry
Reproducibility of Results
Virology
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Zdroj: International Journal of Molecular Sciences
Volume 21
Issue 7
International Journal of Molecular Sciences, Vol 21, Iss 2574, p 2574 (2020)
International journal of environmental research and public health, 21(7):2574
ISSN: 1422-0067
DOI: 10.3390/ijms21072574
Popis: The pandemic novel coronavirus infection, Coronavirus Disease 2019 (COVID-19), has affected at least 190 countries or territories, with 465,915 confirmed cases and 21,031 deaths. In a containment-based strategy, rapid, sensitive and specific testing is important in epidemiological control and clinical management. Using 96 SARS-CoV-2 and 104 non-SARS-CoV-2 coronavirus genomes and our in-house program, GolayMetaMiner, four specific regions longer than 50 nucleotides in the SARS-CoV-2 genome were identified. Primers were designed to target the longest and previously untargeted nsp2 region and optimized as a probe-free real-time reverse transcription-polymerase chain reaction (RT-PCR) assay. The new COVID-19-nsp2 assay had a limit of detection (LOD) of 1.8 TCID50/mL and did not amplify other human-pathogenic coronaviruses and respiratory viruses. Assay reproducibility in terms of cycle threshold (Cp) values was satisfactory, with the total imprecision (% CV) values well below 5%. Evaluation of the new assay using 59 clinical specimens from 14 confirmed cases showed 100% concordance with our previously developed COVID-19-RdRp/Hel reference assay. A rapid, sensitive, SARS-CoV-2-specific real-time RT-PCR assay, COVID-19-nsp2, was developed.
Databáze: OpenAIRE